← Leaderboards
Sylvie Garneau-Tsodikova
University Of Michigan At Ann Arbor
$5,849,312
Attributed
$5,849,312
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2M · FY2011–21$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$5,849,312 · 2
By mechanism
R01$4,399,657 · 1
S10$1,449,655 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Bryan E Pfingst$11,409,389
- Jochen Schacht$8,045,503
- Alfred Nuttal$788,205
- Kathleen L Collins$36,100,709
- Oren Shalom Rom$3,844,260
Others in their field
Top investigators on “Structure”
- David Heimbrook · Leidos Biomedical Research, Inc.$475,333,582
- Barton F Haynes · Duke University$444,977,767
- Lawrence Corey · Fred Hutchinson Cancer Center$334,646,086
- Gary D Acton · University Of California-Davis$320,373,312
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Michael David Hughes · Harvard University D/B/A Harvard School Of Public Health$315,257,203
Research focus
StructureResistance MechanismAnalogPreventPharmaceutical PreparationsMycobacterium TuberculosisAcetyltransferaseCombatInhibitor/AntagonistInnovationKanamycin AComplexLeadAminoglycosidesDrug ResistanceAnti-Bacterial AgentsAntibioticsBiochemicalBiologicalDrug Resistance In TuberculosisExtreme Drug Resistant TuberculosisBacteriaIn VitroResistance
Grant awards (11)
Novel aminoglycoside adjuvants and stand-alone agents to combat tuberculosis$548,046
R01 · FY2021 · AI · contact PI
Bruker AVANCE NEO 600 MHz High-Performance Digital NMR Spectrometer$1,449,655
S10 · FY2020 · OD · contact PI
Novel aminoglycoside adjuvants and stand-alone agents to combat tuberculosis$549,836
R01 · FY2020 · AI · contact PI
Novel aminoglycoside adjuvants and stand-alone agents to combat tuberculosis$549,255
R01 · FY2019 · AI · contact PI
Novel aminoglycoside adjuvants and stand-alone agents to combat tuberculosis$544,540
R01 · FY2018 · AI · contact PI
Novel aminoglycoside adjuvants and stand-alone agents to combat tuberculosis$535,976
R01 · FY2017 · AI · contact PI
Chemoenzymatic studies of aminoglycoside-resistance enzymes towards new drugs$411,807
R01 · FY2014 · AI · contact PI
Chemoenzymatic studies of aminoglycoside-resistance enzymes towards new drugs$403,574
R01 · FY2013 · AI · contact PI
Chemoenzymatic studies of aminoglycoside-resistance enzymes towards new drugs$315,788
R01 · FY2012 · AI · contact PI
Chemoenzymatic studies of aminoglycoside-resistance enzymes towards new drugs$83,153
R01 · FY2012 · AI · contact PI
Chemoenzymatic studies of aminoglycoside-resistance enzymes towards new drugs$457,682
R01 · FY2011 · AI · contact PI